Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?

By sjmartinez • June 21, 2023

Chester RC, Parikh RV. Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance? Circ Cardiovasc Interv. 2023 Jun;16(6):e013113. doi: 10.1161/CIRCINTERVENTIONS.123.013113. Epub 2023 Jun 20. PMID: 37339236.

Tags: angiography, Cardiology/Epi, coronary artery disease, drug-eluting stents, Editorials, percutaneous coronary intervention, Publications

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. Heart Rhythm. 2024 May;21(5):710-711. doi: 10.1016/j.hrthm.2024.03.016. PMID: 38692819.

Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice

Kalanski S, Pradhan S, Hon A, Xia Y, Safvati N, Rivera JC, Lu M, Demer LL, Tintut Y. Effects of Empagliflozin on vascular and skeletal[...]

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. JACC Clin Electrophysiol. 2024 Apr 19:S2405-500X(24)00185-3. doi: 10.1016/j.jacep.2024.03.004.[...]